Unipharm navigates tricky IPO market to raise €136m

dublin_ireland_fotolia_230px
By Aidan Gregory
15 Jul 2019

Unipharm, the Irish healthcare services company, has managed to successfully price its €136m IPO in London and Dublin, despite price sensitivity among investors leading to the cancellation of two significant IPOs last week.

Despite equity markets reaching new all-time highs on Friday, the IPO of AB InBev’s Asian subsidiary, which would have been the largest flotation of the year, was pulled due to weak demand from institutional investors. 

In the UK, ReAssure, the UK closed book life insurance division of Swiss ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.